Secondary Outcome(s)
|
Changes in depression level from baseline to 2, 4, and 6 weeks measured with the Six-item Hamilton Depression Scale
[Time Frame: At baseline and 2, 4, and 6 weeks after baseline]
|
Changes in quality of life from baseline to post-test (6 weeks) measured with the WHO-Five Well-being Index
[Time Frame: At baseline and 6 weeks after baseline]
|
Changes in quality of life from post-test (6 weeks) to follow-up (32 weeks) measured with the WHO-Five Well-being Index
[Time Frame: 6 and 32 weeks after baseline]
|
Changes in worrying from baseline to post-test (6 weeks) measured with the Penn State Worry Questionnaire Past Week
[Time Frame: At baseline and 6 weeks after baseline]
|
Episodes of deliberate self-harm the last six weeks measured a self-report questionnaire
[Time Frame: 38 weeks after baseline (only participants in the control condition)]
|
Changes in suicidal thoughts from baseline to post-test (6 weeks) and follow-up (32 weeks) measured with the Beck Scale for Suicide Ideation
[Time Frame: At baseline, and 6 and 32 weeks after baseline]
|
Production loss from post-test (6 weeks) to follow-up (32 weeks) measured with the Trimbos and iMTA questionnaire for Costs associated with Psychiatric Illness
[Time Frame: 6 and 32 weeks after baseline]
|
Changes in suicidal thoughts from post-test (6 weeks) to follow-up (32 weeks) measured with the Suicidal Ideation Attributes Scale
[Time Frame: 6 and 32 weeks after baseline]
|
Health care utilization from post-test (6 weeks) to follow-up (32 weeks) measured with the National Prescription Registry
[Time Frame: 6 and 32 weeks after baseline]
|
Death by suicide measured with the data extract from the Danish Cause of Death Register; (ICD-10: X60-X84)
[Time Frame: 38 weeks after baseline (only participants in the control condition)]
|
Death by suicide measured with the data extract from the Danish Cause of Death Register; (ICD-10: X60-X84)
[Time Frame: 6 weeks after baseline]
|
Changes in suicidal thoughts from follow-up (32 weeks) to 34, 36, and 38 weeks in suicidal thoughts measured with the Beck Scale for Suicide Ideation (only for participants in the control condition who decides to start the self-help intervention)
[Time Frame: At 32, 34, 36, and 38 weeks after baseline]
|
Changes in depression level from post-test (6 weeks) to follow-up (32 weeks) measured with the Six-item Hamilton Depression Scale
[Time Frame: 6 and 32 weeks after baseline]
|
Episodes of deliberate self-harm the last six months measured a self-report questionnaire
[Time Frame: 32 weeks after baseline]
|
Changes in hopelessness from baseline to post-test (6 weeks) measured with the Beck Hopelessness Scale
[Time Frame: At baseline and 6 weeks after baseline]
|
Changes in hopelessness from post-test (6 weeks) to follow-up (32 weeks) measured with the Beck Hopelessness Scale
[Time Frame: 6 and 32 weeks after baseline]
|
Episodes of deliberate self-harm the last six weeks measured a self-report questionnaire
[Time Frame: 6 weeks after baseline]
|
Changes in suicidal thoughts from baseline to post-test (6 weeks) measured with the Suicidal Ideation Attributes Scale
[Time Frame: At baseline and 6 weeks after baseline]
|
Health care utilization from post-test (6 weeks) to follow-up (32 weeks) measured with The National Patient Register
[Time Frame: 6 and 32 weeks after baseline]
|
Health care utilization from baseline to post-test (6 weeks) measured with National Health Service Register
[Time Frame: At baseline and 6 weeks after baseline]
|
Health care utilization from post-test (6 weeks) to follow-up (32 weeks) measured with the Psychiatric Central Research Register
[Time Frame: 6 and 32 weeks after baseline]
|
Production loss from baseline to post-test (6 weeks) measured with the Trimbos and iMTA questionnaire for Costs associated with Psychiatric Illness
[Time Frame: At baseline and 6 weeks after baseline]
|
Death by suicide measured with the data extract from the Danish Cause of Death Register; (ICD-10: X60-X84)
[Time Frame: 32 weeks after baseline]
|
Health care utilization from baseline to post-test (6 weeks) measured with the National Prescription Registry
[Time Frame: At baseline and 6 weeks after baseline]
|
Changes in worrying from post-test (6 weeks) to follow-up (32 weeks) measured with the Penn State Worry Questionnaire Past Week
[Time Frame: 6 and 32 weeks after baseline]
|
Episodes of deliberate self-harm the last six weeks measured with data from the Danish National Patient Register.
[Time Frame: 6 weeks after baseline]
|
Episodes of deliberate self-harm the last six months measured with data from the Danish National Patient Register
[Time Frame: 32 weeks after baseline]
|
Health care utilization from baseline to post-test (6 weeks) measured with the Psychiatric Central Research Register
[Time Frame: At baseline and 6 weeks after baseline]
|
Health care utilization from post-test (6 weeks) to follow-up (32 weeks) measured with National Health Service Register
[Time Frame: 6 and 32 weeks after baseline]
|
Episodes of deliberate self-harm the last six weeks measured with data from the Danish National Patient Register
[Time Frame: 38 weeks after baseline (only participants in the control condition)]
|
Health care utilization from baseline to post-test (6 weeks) measured with The National Patient Register
[Time Frame: At baseline and 6 weeks after baseline]
|